Literature DB >> 11508872

Elevated serum levels of S-100B reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma.

P Biberthaler1, T Mussack, E Wiedemann, T Gilg, M Soyka, G Koller, K J Pfeifer, U Linsenmaier, W Mutschler, C Gippner-Steppert, M Jochum.   

Abstract

Elevated systemic levels of S-100B are proposed as a potential indicator of brain damage in identifying high-risk patients after mild head trauma (MHT). Although incidence of alcohol intoxication is high in these patients, the influence of alcohol intoxication on S-100B levels is unclear. Therefore, the aim of our study was to investigate serum concentrations of S-100B in intoxicated (group 1) and sober (group 2) patients after MHT in comparison with those of mild (group 3) or severely intoxicated (group 4) individuals without trauma. S-100B was significantly increased in MHT patients exhibiting posttraumatic lesions in initial cranial computed tomography scan. Alcohol intoxication did not elevate S-100B levels in group 3 or 4 subjects. Our data indicate for the first time that alcohol intoxication does not influence the diagnostic value of S-100B measurements in patients after MHT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11508872     DOI: 10.1097/00024382-200116020-00002

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

1.  Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department.

Authors:  Eun-Jee Oh; Young-Min Kim; Dong-Wook Jegal; Jimin Kahng; Yeon-Joon Park; Kyungja Han
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 2.  Traumatic alterations in consciousness: traumatic brain injury.

Authors:  Brian J Blyth; Jeffrey J Bazarian
Journal:  Emerg Med Clin North Am       Date:  2010-08       Impact factor: 2.264

Review 3.  S100B, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Michael Amoo; Jack Henry; Philip J O'Halloran; Paul Brennan; Mohammed Ben Husien; Matthew Campbell; John Caird; Mohsen Javadpour; Gerard F Curley
Journal:  Neurosurg Rev       Date:  2021-10-28       Impact factor: 3.042

Review 4.  Blood biomarkers for brain injury: What are we measuring?

Authors:  Keisuke Kawata; Charles Y Liu; Steven F Merkel; Servio H Ramirez; Ryan T Tierney; Dianne Langford
Journal:  Neurosci Biobehav Rev       Date:  2016-05-12       Impact factor: 8.989

5.  ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.

Authors:  Nicola Marchi; Peter Mazzone; Vincent Fazio; Tarek Mekhail; Thomas Masaryk; Damir Janigro
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

6.  Extracranial sources of S100B do not affect serum levels.

Authors:  Nancy Pham; Vincent Fazio; Luca Cucullo; Qingshan Teng; Peter Biberthaler; Jeffrey J Bazarian; Damir Janigro
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

7.  The addition of S100B to guidelines for management of mild head injury is potentially cost saving.

Authors:  Olga Calcagnile; Anders Anell; Johan Undén
Journal:  BMC Neurol       Date:  2016-10-20       Impact factor: 2.474

8.  Clinical validation of S100B use in management of mild head injury.

Authors:  Olga Calcagnile; Linda Undén; Johan Undén
Journal:  BMC Emerg Med       Date:  2012-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.